Abeona Therapeutics (ABEO) Earnings Analysis

Abeona Therapeutics (ABEO) next reports earnings on 2026-08-13, consensus EPS -0.23 USD. Last quarter (2026-03-17) it beat with EPS -0.34 USD vs -0.35 USD est (+2.9%). It has beaten estimates in 5/6 recent quarters (83%). Trailing P/E 5.00.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does ABEO next report earnings?

Next earnings date2026-08-13
Consensus EPS estimate-0.23 USD
Revenue estimate0.01B

ABEO earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-17-0.34 USD-0.35 USD+2.9%Beat
2025-08-141.71 USD-0.39 USD+538.5%Beat
2025-05-15-0.24 USD-0.35 USD+31.4%Beat
2025-03-20-0.24 USD-0.43 USD+44.2%Beat
2024-11-14-0.31 USD-0.38 USD+18.4%Beat
2024-08-12-0.75 USD-0.33 USD-127.3%Miss

Beat rate: 5/6 (83%) over reported quarters with consensus data.

ABEO valuation and analyst view

Trailing P/E5.00
Trailing EPS1.168 USD
Price / book2.51
Dividend yield0.00%
Market cap0.37B
Analyst consensusBuy (6 buy / 3 hold / 0 sell)
Avg price target17 USD

Related research pages

Frequently asked questions

When is Abeona Therapeutics (ABEO)'s next earnings date?

Abeona Therapeutics is next scheduled to report on 2026-08-13, with a consensus EPS estimate of -0.23 USD and revenue estimate of 0.01B.

Did ABEO beat earnings last quarter?

In its 2026-03-17 report, ABEO posted EPS of -0.34 USD versus a -0.35 USD estimate — a beat of 2.9%.

What is ABEO's earnings track record?

Over the last 6 reported quarters with consensus data, ABEO beat estimates 5 times (83%).

What is ABEO's current P/E ratio and EPS?

ABEO trades at a trailing P/E of 5.00 on trailing EPS of 1.1680665026283572 USD.

What do analysts rate ABEO?

Analyst consensus is "Buy" across 9 ratings (0 strong buy, 6 buy, 3 hold, 0 sell, 0 strong sell). Average 12-month price target: 17 USD.